Germany· DE-A57-d2d628668efd865c
Glycylpressin
A terlipressin product containing terlipressin, registered in Germany by Ferring Gmbh. The same ATC class is registered in 15 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Terlipressin is registered in 15 of 19 countries.
Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Terlipressin · ATC H01BA04
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Terlipressin
- Manufacturer
- Ferring Gmbh
- Country
- Germany (DE)
- ATC code
- H01BA04
- ATC class
- Terlipressin
- Defined daily dose
- 12 mg, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Terlipressin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGlypressin 1mg powder and solvent for solution for injection vialsFerring Pharmaceuticals Ltd
- SpainGLYPRESSIN 1 mg SOLUCION INYECTABLEFerring S.A.U.
- FranceACETATE DE TERLIPRESSINE EVER PHARMA 0,2 mg/ml, solution injectableEVER VALINJECT (AUTRICHE)
- PolandGlypressinFerring GmbH
- SwitzerlandCurapressin 1 mg/5 ml, InjektionslösungCuratis AG
- IcelandGlypressinFerring Lægemidler A/S
- NetherlandsGlypressin 0,1 mg/ml, oplossing voor injectieFerring B.V.
- United StatesTerlivazMallinckrodt Hospital Products Inc.
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Glycylpressin, Terlipressinacetat Ever Pharma
- Bulgaria · Терлипресин Ацетат Ever Pharma
- Czechia · Remestyp, Terlipresin Acetát Ever Pharma
- Spain · Terlipresina Acetato Ever Pharma
- France · Acetate De Terlipressine Ever Pharma
- Hungary · Glypressin
- Ireland · Terlipressin Acetate Ever Pharma
- Italy · Glipressina, Terlipressina Acetato Ever Pharma
- Poland · Terlipressini Acetas Ever Pharma
- Portugal · Glypressine, Terlipressina Ever Pharma
- Romania · Acetat De Terlipresină Ever Pharma
- Slovakia · Remestyp, Terlipresín Ever Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b50b913c-a6ef-4501-9483-b6fb5cca13bf GET /v1/drugs/b50b913c-a6ef-4501-9483-b6fb5cca13bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Terlipressin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about terlipressin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.